Subclinical myocardial injury in small-for-gestational-age neonates

T. Chaiworapongsa, J. Espinoza, J. Yoshimatsu, K. Kalache, S. Edwin, S. Blackwell, B. H. Yoon, Jorge Tolosa, M. Silva, E. Behnke, R. Gomez, R. Romero

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objective: Small-for-gestational-age (SGA) infants are at risk for premature death from cardiovascular disease (myocardial infarction and stroke), hypertension, and diabetes in adult life. Severe intrauterine growth restriction is often associated with subclinical cardiovascular abnormalities detectable during fetal echocardiography. The objective of this study was to determine whether SGA newborns have evidence of myocardial injury at birth. Study design: Cardiac troponin I, a specific marker of myocardial injury widely used for the diagnosis of myocardial infarction in adults, was determined in umbilical cord blood. Umbilical cord venous blood was obtained at the time of birth from 72 SGA newborns (birth weight below the 10th centile for gestational age) and 309 newborns whose birth weights were appropriate for gestational age (AGA). Cardiac troponin I was determined with a commercially available immunoassay (sensitivity 0.2 ng/ml) employed in clinical laboratories (Immulite 2000, Diagnostic Products Corp., Los Angeles, CA). Results: Cardiac troponin I was not detectable in any of the blood samples from AGA infants. In contrast, 4.2% (3/72) of SGA infants had detectable cardiac troponin I in umbilical cord blood (Fisher's exact test, p = 0.007). Conclusion: A subgroup of SGA newborns undergoes myocardial injury before birth. This insult may predispose to the development of adult premature cardiovascular disease and death.

Original languageEnglish (US)
Pages (from-to)385-390
Number of pages6
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume11
Issue number6
StatePublished - 2002
Externally publishedYes

Fingerprint

Gestational Age
Troponin I
Newborn Infant
Wounds and Injuries
Fetal Blood
Birth Injuries
Small for Gestational Age Infant
Birth Weight
Cardiovascular Diseases
Myocardial Infarction
Cardiovascular Abnormalities
Premature Mortality
Los Angeles
Immunoassay
Echocardiography
Stroke
Parturition
Hypertension
Growth

Keywords

  • Myocardial injury
  • Small for gestational age
  • Troponin I

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Chaiworapongsa, T., Espinoza, J., Yoshimatsu, J., Kalache, K., Edwin, S., Blackwell, S., ... Romero, R. (2002). Subclinical myocardial injury in small-for-gestational-age neonates. Journal of Maternal-Fetal and Neonatal Medicine, 11(6), 385-390.

Subclinical myocardial injury in small-for-gestational-age neonates. / Chaiworapongsa, T.; Espinoza, J.; Yoshimatsu, J.; Kalache, K.; Edwin, S.; Blackwell, S.; Yoon, B. H.; Tolosa, Jorge; Silva, M.; Behnke, E.; Gomez, R.; Romero, R.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 11, No. 6, 2002, p. 385-390.

Research output: Contribution to journalArticle

Chaiworapongsa, T, Espinoza, J, Yoshimatsu, J, Kalache, K, Edwin, S, Blackwell, S, Yoon, BH, Tolosa, J, Silva, M, Behnke, E, Gomez, R & Romero, R 2002, 'Subclinical myocardial injury in small-for-gestational-age neonates', Journal of Maternal-Fetal and Neonatal Medicine, vol. 11, no. 6, pp. 385-390.
Chaiworapongsa T, Espinoza J, Yoshimatsu J, Kalache K, Edwin S, Blackwell S et al. Subclinical myocardial injury in small-for-gestational-age neonates. Journal of Maternal-Fetal and Neonatal Medicine. 2002;11(6):385-390.
Chaiworapongsa, T. ; Espinoza, J. ; Yoshimatsu, J. ; Kalache, K. ; Edwin, S. ; Blackwell, S. ; Yoon, B. H. ; Tolosa, Jorge ; Silva, M. ; Behnke, E. ; Gomez, R. ; Romero, R. / Subclinical myocardial injury in small-for-gestational-age neonates. In: Journal of Maternal-Fetal and Neonatal Medicine. 2002 ; Vol. 11, No. 6. pp. 385-390.
@article{e0c6f3b9be944b6cafd7e6ad6dc5f99f,
title = "Subclinical myocardial injury in small-for-gestational-age neonates",
abstract = "Objective: Small-for-gestational-age (SGA) infants are at risk for premature death from cardiovascular disease (myocardial infarction and stroke), hypertension, and diabetes in adult life. Severe intrauterine growth restriction is often associated with subclinical cardiovascular abnormalities detectable during fetal echocardiography. The objective of this study was to determine whether SGA newborns have evidence of myocardial injury at birth. Study design: Cardiac troponin I, a specific marker of myocardial injury widely used for the diagnosis of myocardial infarction in adults, was determined in umbilical cord blood. Umbilical cord venous blood was obtained at the time of birth from 72 SGA newborns (birth weight below the 10th centile for gestational age) and 309 newborns whose birth weights were appropriate for gestational age (AGA). Cardiac troponin I was determined with a commercially available immunoassay (sensitivity 0.2 ng/ml) employed in clinical laboratories (Immulite 2000, Diagnostic Products Corp., Los Angeles, CA). Results: Cardiac troponin I was not detectable in any of the blood samples from AGA infants. In contrast, 4.2{\%} (3/72) of SGA infants had detectable cardiac troponin I in umbilical cord blood (Fisher's exact test, p = 0.007). Conclusion: A subgroup of SGA newborns undergoes myocardial injury before birth. This insult may predispose to the development of adult premature cardiovascular disease and death.",
keywords = "Myocardial injury, Small for gestational age, Troponin I",
author = "T. Chaiworapongsa and J. Espinoza and J. Yoshimatsu and K. Kalache and S. Edwin and S. Blackwell and Yoon, {B. H.} and Jorge Tolosa and M. Silva and E. Behnke and R. Gomez and R. Romero",
year = "2002",
language = "English (US)",
volume = "11",
pages = "385--390",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Subclinical myocardial injury in small-for-gestational-age neonates

AU - Chaiworapongsa, T.

AU - Espinoza, J.

AU - Yoshimatsu, J.

AU - Kalache, K.

AU - Edwin, S.

AU - Blackwell, S.

AU - Yoon, B. H.

AU - Tolosa, Jorge

AU - Silva, M.

AU - Behnke, E.

AU - Gomez, R.

AU - Romero, R.

PY - 2002

Y1 - 2002

N2 - Objective: Small-for-gestational-age (SGA) infants are at risk for premature death from cardiovascular disease (myocardial infarction and stroke), hypertension, and diabetes in adult life. Severe intrauterine growth restriction is often associated with subclinical cardiovascular abnormalities detectable during fetal echocardiography. The objective of this study was to determine whether SGA newborns have evidence of myocardial injury at birth. Study design: Cardiac troponin I, a specific marker of myocardial injury widely used for the diagnosis of myocardial infarction in adults, was determined in umbilical cord blood. Umbilical cord venous blood was obtained at the time of birth from 72 SGA newborns (birth weight below the 10th centile for gestational age) and 309 newborns whose birth weights were appropriate for gestational age (AGA). Cardiac troponin I was determined with a commercially available immunoassay (sensitivity 0.2 ng/ml) employed in clinical laboratories (Immulite 2000, Diagnostic Products Corp., Los Angeles, CA). Results: Cardiac troponin I was not detectable in any of the blood samples from AGA infants. In contrast, 4.2% (3/72) of SGA infants had detectable cardiac troponin I in umbilical cord blood (Fisher's exact test, p = 0.007). Conclusion: A subgroup of SGA newborns undergoes myocardial injury before birth. This insult may predispose to the development of adult premature cardiovascular disease and death.

AB - Objective: Small-for-gestational-age (SGA) infants are at risk for premature death from cardiovascular disease (myocardial infarction and stroke), hypertension, and diabetes in adult life. Severe intrauterine growth restriction is often associated with subclinical cardiovascular abnormalities detectable during fetal echocardiography. The objective of this study was to determine whether SGA newborns have evidence of myocardial injury at birth. Study design: Cardiac troponin I, a specific marker of myocardial injury widely used for the diagnosis of myocardial infarction in adults, was determined in umbilical cord blood. Umbilical cord venous blood was obtained at the time of birth from 72 SGA newborns (birth weight below the 10th centile for gestational age) and 309 newborns whose birth weights were appropriate for gestational age (AGA). Cardiac troponin I was determined with a commercially available immunoassay (sensitivity 0.2 ng/ml) employed in clinical laboratories (Immulite 2000, Diagnostic Products Corp., Los Angeles, CA). Results: Cardiac troponin I was not detectable in any of the blood samples from AGA infants. In contrast, 4.2% (3/72) of SGA infants had detectable cardiac troponin I in umbilical cord blood (Fisher's exact test, p = 0.007). Conclusion: A subgroup of SGA newborns undergoes myocardial injury before birth. This insult may predispose to the development of adult premature cardiovascular disease and death.

KW - Myocardial injury

KW - Small for gestational age

KW - Troponin I

UR - http://www.scopus.com/inward/record.url?scp=0036022647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036022647&partnerID=8YFLogxK

M3 - Article

C2 - 12389653

AN - SCOPUS:0036022647

VL - 11

SP - 385

EP - 390

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 6

ER -